AMUSA S. ADEBAYO, PH.D.
Professor, Pharmaceutical Sciences
University of Ibadan (Nigeria) – Ph.D. in Pharmaceutics
Obafemi Awolowo University (Nigeria) – M.Sc. in Pharmaceutics; MBA.
Obafemi Awolowo University (Nigeria) – B. Pharm.
University of Illinois (Chicago) – MSHI (online, ongoing)
Fields of Interest
Dosage form design & development
Pharmaceutical testing and analysis
Dr. Amusa S. Adebayo received his Bachelor of Pharmacy (B. Pharm) in 1989, and his Master of Science in Pharmaceutics in 1995 from the Faculty of Pharmacy, and his Master of Business Administration (MBA) in 1999 from the Faculty of Administration of the Obafemi Awolowo University (Nigeria). He received his Ph.D. in 2001 from the University of Ibadan (Nigeria). Following a twelve-year tenure as an Associate faculty in Pharmaceutics and Head of the Drug Production Unit of the Faculty of Pharmacy, he joined the University of Technology, Jamaica, where he led the establishment of the first graduate program (M.Phil. Pharmaceutics) in the College of Health and Applied Sciences in 2006. Dr Adebayo had extensive leadership and administrate experiences at the UTech (Jamaica), where he was Head of School of Pharmacy and Health Sciences, and later head of the new School of Pharmacy between 2002 and 2010. He worked as Senior Lecturer in Pharmaceutics at the University of the West Indies, Trinidad and Tobago for about 2 years before joining the Roosevelt University College of Pharmacy as an inaugural faculty in Biopharmaceutics and Pharmacokinetics in 2011.
Dr. Adebayo co-mentored two PhD (Pharmaceutical Sciences) students at the University of the West Indies and several MPhil students both at the UTech, Jamaica, and the UWI Mona and UWI St. Augustine campuses and 3 MSc (Biotechnology) graduates at the Roosevelt University.
Dr. Adebayo is a member of the American Association of Pharmaceutical Sciences, The American Association of Colleges of Pharmacy (AACP), The International Academy of Compounding Pharmacists (IACP) and the International Pharmaceutical Federation (FIP).
Dr. Adebayo’s current research is focused on niosomes encapsulation of medicinal agents to mitigate bacterial resistance, and the development and evaluation of quality and stability of age-appropriate, extemporaneously compounded drug products.
Dr. Adebayo has authored 28 peer-reviewed research articles, 33 symposium abstracts, and a book chapter on pharmaceutical capsules. He currently serves on the editorial review board of several peer-reviewed pharmaceutical and research journals.